Google News
logo
Daily Current Affairs
Which Country first mRNA-based Omicron-specific booster vaccine approved?
A)
USA
B)
China
C)
Russia
D)
India

Correct Answer :   India


The Drugs Controller General of India (DCGI) has approved the country's first mRNA-based Omicron-specific booster vaccine, which is developed by Gennova Biopharmaceuticals Ltd, for emergency use.

* The Pune-based company on Tuesday (20th June 2023) released a press release to announce that its vaccine against the Omicron variant of SARS-CoV-2, which will be available under the name GEMCOVAC-OM, has received Emergency Use Authorization (EUA) from the office of the DCGI.

* According to Gennova, GEMCOVAC-OM is the first booster COVID-19 vaccine developed in India against the highly transmissible Omicron variant. Approximately 3000 individuals received the vaccine in the Phase-II/ III trials clinical trial conducted at 20 centers across 13 cities in India.

* The vaccine was found safe, well tolerated as well as demonstrated robust immune responses.


Why do we need Omicron-Specific Booster Vaccine?

* COVID-19 vaccines that are currently used as precautionary/booster doses in India are designed to fight against the ancestral strain of SARS-CoV-2. These existing vaccines may increase the antibody titers, but they may not be effective against the circulating Omicron variant of SARS-CoV-2.

* Hence the need to develop antibodies and memory immune responses specific to the Omicron variant to reduce the probability of infection and hospitalization as well as prevent future waves of the COVID-19 pandemic. The development of GEMCOVAC-OM specifically addresses this gap, the company stated..

Source : The Health Site

Published On : June 21, 2023
Advertisement